Medicate: Healthcare Opportunities Beyond the Crisis

Medicate: Healthcare Opportunities Beyond the Crisis

Date/Time
May 15, 2020
10:00 am - 11:00 am


What conversations are going on in healthcare boardrooms right now? How will the COVID-19 crisis impact healthcare dealmaking?  What sectors will private equity investors and strategic buyers continue to target?  What will they avoid?  How will key healthcare stakeholders re-evaluate their M&A strategies?  Join us on Friday, May 15th, 2020 for an exclusive video panel discussion with highly regarded healthcare dealmakers for real-time, in-depth perspectives.

Before we hear from healthcare executives on the front lines of M&A and investing, we’ll hear from Andreas Dirnagl, MUFG’s Head of Global Healthcare Research, for an update on the economic impact of COVID-19 across the healthcare ecosystem.

Date: Friday, May 15, 2020
Time: 10 a.m. PST / 1 p.m. EST
Duration: 1 hour

Opening Remarks & Moderators
image-22image-48
Adam Abramowitz
Managing Director, Intrepid
Jonathan Bluth
Director, Intrepid
Healthcare Market Observations 
image-45

Andreas J. Dirnagl
Managing Director, MUFG Healthcare

Panelists 
image-46image-47

Jeff Bailet, MD
President & CEO, Altais

Jamey Edwards
CEO, Cloudbreak

image-44image-40
Mehran Ahmed
Principal, Webster Equity
Beth Everett
Managing Director, MUFG Healthcare